August 18, 2022
Naveen Pemmaraju, MD
Dr. Naveen Pemmaraju discusses the current treatment standards for both polycythemia vera and essential thrombocythemia, highlighting the needs of high-risk patients.
August 18, 2022
Naveen Pemmaraju, MD
Dr. Naveen Pemmaraju discusses the current treatment standards for both polycythemia vera and essential thrombocythemia, highlighting the needs of high-risk patients.